News

Viral Genetics has entered into an exclusive license agreement with the University of Colorado to develop cancer therapies based on the work of Karen Newell, a professor of

Millipore has introduced Scepter, a handheld, automated cell counter, at the American Society of Cell Biology Annual Meeting in San Diego. Scepter miniaturizes Coulter cell counting technology found

QuantRx Biomedical has introduced new point-of-care (POC) diagnostic reader device, Q-Reader, at MEDICA 2009 in Dusseldorf, Germany. The Q-Reader addresses the performing of advanced medical diagnostic procedures where

Cegedim Dendrite will deploy an Amdocs help desk solution to deliver enhanced support services to its worldwide customer base. Amdocs is a provider of Customer Experience Systems (CES).

RTS Life Science plans to launch its Tube Auditor instrument. The Tube Auditor features vision technology (patent pending), which allows fast and accurate volume measurement of samples, and

BiondVax has completes the Phase I/II clinical trial of the Multimeric-001 Universal Flu vaccine. The trials were conducted at the Sourasky Medical Center in Tel Aviv, Israel. The

Van Andel Institute (VAI) has expanded its 240,000 square foot facility with an investment of $178m on December 8, 2009. The expanded facility creates economic and scientific opportunity

McKesson is set to introduce the PROmanager-Rx system, a solution that enables hospitals to fully automate the dispensing of tablets, capsules, and other oral solid medications that come pre-packaged from

Facet Biotech (Facet) and Bristol-Myers Squibb have reported positive data from a phase I/II study of Elotuzumab, an investigational humanised antibody being studied for the treatment of relapsed